位于剑桥的阿登布鲁克医院 将生产CAR-T细胞 以推进癌症治疗 Addenbrooke's Hospital in Cambridge will produce CAR-T cells to advance cancer treatment.

联合王国剑桥的Addenbrooke医院不久将生产Chimeric 抗原受体(CAR)-T细胞,成为联合王国为数不多的设施之一。 Addenbrooke's Hospital in Cambridge, UK, will soon manufacture Chimeric Antigen Receptor (CAR)-T cells, becoming one of the few UK facilities to do so. 在国家卫生研究所赠款140万英镑的资助下,剑桥细胞治疗实验室的扩大将包括新的清洁室,将在12至18个月内开放。 Funded by a £1.4 million grant from the National Institute of Health Research, the expansion of the Cambridge Cellular Therapy Laboratory will include new cleanrooms, set to open in 12 to 18 months. 该倡议旨在支持对癌症和自免疫疾病进行临床试验和可能的大规模治疗。 This initiative aims to support clinical trials and potentially scale treatments for cancer and autoimmune diseases.